D’Alessio, F.; Lione, L.; Salvatori, E.; Bucci, F.; Muzi, A.; Roscilli, G.; Compagnone, M.; Pinto, E.; Battistuzzi, G.; Conforti, A.;
et al. Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms. Vaccines 2023, 11, 678.
https://doi.org/10.3390/vaccines11030678
AMA Style
D’Alessio F, Lione L, Salvatori E, Bucci F, Muzi A, Roscilli G, Compagnone M, Pinto E, Battistuzzi G, Conforti A,
et al. Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms. Vaccines. 2023; 11(3):678.
https://doi.org/10.3390/vaccines11030678
Chicago/Turabian Style
D’Alessio, Federico, Lucia Lione, Erika Salvatori, Federica Bucci, Alessia Muzi, Giuseppe Roscilli, Mirco Compagnone, Eleonora Pinto, Gianfranco Battistuzzi, Antonella Conforti,
and et al. 2023. "Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms" Vaccines 11, no. 3: 678.
https://doi.org/10.3390/vaccines11030678
APA Style
D’Alessio, F., Lione, L., Salvatori, E., Bucci, F., Muzi, A., Roscilli, G., Compagnone, M., Pinto, E., Battistuzzi, G., Conforti, A., Aurisicchio, L., & Palombo, F.
(2023). Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms. Vaccines, 11(3), 678.
https://doi.org/10.3390/vaccines11030678
